November 27, 2018, Coralville, IA. – Emmyon is pleased to announce that the United States Patent and Trademark Office has today issued a new patent for the use of ursolic acid to enhance muscle formation, increase muscle mass, or reduce muscle atrophy. This new patent, which has been exclusively licensed to Emmyon from the University of Iowa Research Foundation, complements and greatly strengthens Emmyon’s IP coverage of ursolic acid in the United States. The patent’s lead inventor is Emmyon’s President, Chris Adams, MD, PhD.